OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications – A pilot study
Tobias Moser, Ferdinand Otto, Ciara K. O’Sullivan, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 59, pp. 103560-103560
Open Access | Times Cited: 13
Tobias Moser, Ferdinand Otto, Ciara K. O’Sullivan, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 59, pp. 103560-103560
Open Access | Times Cited: 13
Showing 13 citing articles:
Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273
Niels J. M. Verstegen, Ruth R Hagen, Jet van den Dijssel, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 20
Niels J. M. Verstegen, Ruth R Hagen, Jet van den Dijssel, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 20
Immunomodulatory Aspects of Therapeutic Plasma Exchange in Neurological Disorders—A Pilot Study
Fabian Foettinger, Georg Pilz, Peter Wipfler, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6552-6552
Open Access | Times Cited: 5
Fabian Foettinger, Georg Pilz, Peter Wipfler, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6552-6552
Open Access | Times Cited: 5
Incidence of multiple sclerosis relapses and pseudo-relapses following COVID-19 vaccination
Amir Labani, Scott Chou, Kasra Kaviani, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 77, pp. 104865-104865
Closed Access | Times Cited: 5
Amir Labani, Scott Chou, Kasra Kaviani, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 77, pp. 104865-104865
Closed Access | Times Cited: 5
Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study
Tobias Moser, Ciara K. O’Sullivan, Ferdinand Otto, et al.
Therapeutic Advances in Neurological Disorders (2022) Vol. 15, pp. 175628642210920-175628642210920
Open Access | Times Cited: 9
Tobias Moser, Ciara K. O’Sullivan, Ferdinand Otto, et al.
Therapeutic Advances in Neurological Disorders (2022) Vol. 15, pp. 175628642210920-175628642210920
Open Access | Times Cited: 9
The immunologic outcomes and adverse events of COVID-19 vaccine booster dose in immunosuppressed people: A systematic review
SeyedAhmad SeyedAlinaghi, Mohsen Dashti, Arian Afzalian, et al.
Preventive Medicine Reports (2024) Vol. 44, pp. 102778-102778
Open Access | Times Cited: 1
SeyedAhmad SeyedAlinaghi, Mohsen Dashti, Arian Afzalian, et al.
Preventive Medicine Reports (2024) Vol. 44, pp. 102778-102778
Open Access | Times Cited: 1
Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell–targeted therapy
Joseph Azar, John P. Evans, Madison H. Sikorski, et al.
JCI Insight (2023) Vol. 8, Iss. 6
Open Access | Times Cited: 3
Joseph Azar, John P. Evans, Madison H. Sikorski, et al.
JCI Insight (2023) Vol. 8, Iss. 6
Open Access | Times Cited: 3
Can B cell‐deficient patients rely on COVID ‐19 vaccine‐induced T‐cell immunity?
Tanaya Shree
British Journal of Haematology (2022) Vol. 197, Iss. 6, pp. 659-661
Open Access | Times Cited: 4
Tanaya Shree
British Journal of Haematology (2022) Vol. 197, Iss. 6, pp. 659-661
Open Access | Times Cited: 4
Impact of Continuous Ofatumumab Exposure During Pregnancy in Multiple Sclerosis
Simon Hefner, Tiago Lerda Casaccia, Edda Hofstaetter, et al.
Neurology Clinical Practice (2024) Vol. 15, Iss. 1
Closed Access
Simon Hefner, Tiago Lerda Casaccia, Edda Hofstaetter, et al.
Neurology Clinical Practice (2024) Vol. 15, Iss. 1
Closed Access
Impact of immunotherapies on COVID-19 outcomes in multiple sclerosis patients
Chiara Zanetta, Maria A. Rocca, Massimo Filippi
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 5, pp. 495-512
Closed Access | Times Cited: 2
Chiara Zanetta, Maria A. Rocca, Massimo Filippi
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 5, pp. 495-512
Closed Access | Times Cited: 2
Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy
Sam Bazzi, Cole Maguire, Nisha Holay, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 68, pp. 104195-104195
Open Access | Times Cited: 1
Sam Bazzi, Cole Maguire, Nisha Holay, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 68, pp. 104195-104195
Open Access | Times Cited: 1
Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery
Julia Feige, Klaus Berek, Michael Seiberl, et al.
Neurology International (2022) Vol. 14, Iss. 4, pp. 943-951
Open Access | Times Cited: 1
Julia Feige, Klaus Berek, Michael Seiberl, et al.
Neurology International (2022) Vol. 14, Iss. 4, pp. 943-951
Open Access | Times Cited: 1
Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab
Elina Groß-Albenhausen, Alicia Weier, Markus Velten, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access
Elina Groß-Albenhausen, Alicia Weier, Markus Velten, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access
Suppression of de novo antibody responses against SARS-CoV2 and the Omicron variant after mRNA vaccination and booster in patients with B cell malignancies undergoing active treatment, but maintenance of pre-existing antibody levels against endemic viruses
Joseph Azar, John P. Evans, Madison H. Sikorski, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Joseph Azar, John P. Evans, Madison H. Sikorski, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
